Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zheng‐Yang Hao"'
Autor:
Lu-Lu Yang, Wen-Chang Xiao, Huan Li, Zheng-Yang Hao, Gui-Zhi Liu, Dian-Hong Zhang, Lei-Ming Wu, Zheng Wang, Yan-Qing Zhang, Zhen Huang, Yan-Zhou Zhang
Publikováno v:
Cell Death and Disease, Vol 13, Iss 10, Pp 1-12 (2022)
Abstract Ring-finger protein 5 (RNF5) is an E3 ubiquitin ligase which is expressed in a variety of human tissues. RNF5 is involved in the regulation of endoplasmic reticulum stress, inflammation, and innate immunity and plays an important role in the
Externí odkaz:
https://doaj.org/article/5689e6243fcc4f37b56bebea8bab5250
Autor:
Ling‐Yao Kong, Cui Liang, Peng‐Cheng Li, Yi‐Wei Zhang, Sheng‐Dong Feng, Dian‐Hong Zhang, Rui Yao, Lu‐Lu Yang, Zheng‐Yang Hao, Hao Zhang, Xiao‐Xu Tian, Chen‐Ran Guo, Bin‐Bin Du, Jian‐Zeng Dong, Yan‐Zhou Zhang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 21 (2022)
Background Restenosis is one of the main bottlenecks in restricting the further development of cardiovascular interventional therapy. New signaling molecules involved in the progress have continuously been discovered; however, the specific molecular
Externí odkaz:
https://doaj.org/article/e25b5e889fff47428cfc6187c9647133
Autor:
Cui Liang, Pengcheng Li, Chenran Guo, Dianhong Zhang, Lulu Yang, Binbin Du, Zheng-Yang Hao, Lingyao Kong, Yanzhou Zhang, Xiaoxu Tian, Jian-Zeng Dong
Publikováno v:
Journal of Cellular and Molecular Medicine
Cardiac hypertrophy and the resultant heart failure are among the most common causes of morbidity and mortality worldwide; thus, identifying the key factor mediating pathological cardiac hypertrophy is critically important for developing the strategy
Autor:
Huan Li, Leiming Wu, Rui Yao, Jianzeng Dong, Yanzhou Zhang, Binbin Du, Guang-Jian Fan, Pengcheng Li, Jin-Ying Zhang, Jie-Lei Zhang, Zheng Wang, Dianhong Zhang, Yapeng Li, Shou-Jun Wang, Zheng-Yang Hao, Lulu Yang, Cui Liang, Zhen Huang, Lingyao Kong
Publikováno v:
Hepatology (Baltimore, Md.)REFERENCES. 75(5)
Background & aims Nonalcoholic fatty liver disease (NAFLD) is considered as the hepatic manifestation of the metabolic syndrome, which includes insulin resistance (IR), obesity and hyperlipidemia. Nonalcoholic steatohepatitis (NASH) is a progressive